BASKING RIDGE, N.J., Feb. 20, 2013 /PRNewswire/ -- Since Mylan Specialty L.P., the fully-integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), launched the EpiPen4Schools ™ program in August 2012, thousands of schools across the country have elected to participate and redeem free EpiPen ® or EpiPen Jr ® (epinephrine) Auto-Injectors. The program was created to help schools have improved access to epinephrine in the event a person experiences a life-threatening allergic reaction (anaphylaxis) at school.
"When anaphylaxis occurs, every minute matters—even one incident without access to epinephrine is too many. Through EpiPen4Schools we are helping make epinephrine available for those with known life-threatening allergies as well as for those who experience anaphylaxis while at school," said Heather Bresch, CEO of Mylan. "As we continue our commitment to improving access to epinephrine, we are delighted to see the immediate interest and uptake nationwide, and hope it continues. Several cases in schools across the country in which the free EpiPen Auto-Injectors were used to treat an anaphylactic reaction underscore the positive impact of the program."
The program offers four free EpiPen or EpiPen Jr Auto-Injectors, upon qualification, which includes having a valid prescription, to public and private kindergarten, elementary, middle and high schools in the U.S. The products are available in the form of two EpiPen 2-Pak ® cartons, two EpiPen Jr 2-Pak ® cartons or one 2-Pak of each kind. EpiPen Auto-Injectors contain a single dose of epinephrine, which you inject into your outer thigh. EpiPen and EpiPen Jr are intended for immediate self administration as emergency supportive therapy only. Seek immediate emergency medical treatment after use. For complete program details, visit www.EpiPen4Schools.com.
"Starting in the fall of 2012, all Chicago Public Schools (CPS) have undesignated epinephrine auto-injectors, provided through the EpiPen4Schools program. To date, we have already had several events in Chicago schools requiring the use of these EpiPen Auto-Injectors. If symptoms of anaphylaxis are identified, a person should be treated with an epinephrine auto-injector and seek immediate emergency medical care after use," said Ruchi Gupta, M.D., M.P.H., Associate Professor of Pediatrics at Northwestern University and Lurie Children's Hospital. "As we work with CPS to help facilitate the anaphylaxis policies CPS has implemented, we are pleased to see them having the intended effect."Each school should have a comprehensive anaphylaxis action plan that emphasizes avoidance of the allergen. The plan also should include awareness of the risks, preparedness for an emergency and access to two epinephrine auto-injectors and immediate medical care.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV